Kunyu Yang, Xiaomeng Zhang, Lu Wen. "Neoadjuvant ivonescimab (AK112, a PD-1/VEGF bispecific antibody) combined with nab-paclitaxel and cisplatin (AP) for resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC): An exploratory phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6014